⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 7, 2024Insights into ImagingOpen Access

Optimizing ultrafast dynamic contrast-enhanced MRI scan duration in the differentiation of benign and malignant breast lesions

Ying Cao Yao Huang Xianglong Chen Wei Wang Huifang Chen Ting Yin Dominik Nickel Changchun Li Junhua Shao Shi Zhang Xiaoxia Wang Jiuquan Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

To determine the optimal scan duration for ultrafast DCE-MRI in effectively differentiating benign from malignant breast lesions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cao et al. (2024) studied this question.

synapsesocial.com/papers/68e6b291b6db643587633e91 https://doi.org/10.1186/s13244-024-01697-6

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Feasibility of ultrafast DCE-MRI in differentiating benign and malignant breast tumors2024
2The utility of ultrafast MRI and conventional DCE-MRI for predicting histologic aggressiveness in patients with breast cancer2024 · 2 citations
3Dynamic Bilateral Contrast-enhanced MR Imaging of the Breast: Trade-off between Spatial and Temporal ResolutionCohort Study · 2005 · 263 citations
4Performance of low- and high-temporal-resolution DCE-MRI texture analysis in distinguishing breast lesions from background enhancement2025
5Multiple Parameters from Ultrafast Dynamic Contrast-enhanced MRI to Differentiate HER2-Zero, -Low, and -Positive Breast Cancer2025

Initial Experience and Clinical Application of Gadoterate Meglumine in Abbreviated DCE-MRI of the Breast with Ultrafast Imaging.2025
Usefulness of Combined Advanced Dynamic Contrast-Enhanced and Diffusion-Weighted MRI Over Ultrasonography in Differentiating Cancer From Benign Lesions in Dense Breasts2024
Dynamic breast MRI with Flexible Temporal Resolution Aided by Deep Learning2026
The rules of actionable reportingInsights into Imaging · 2026
Patient acceptance and experience with contrast-enhanced mammography in women with a personal history of breast cancer: findings from the COMBO trialInsights into Imaging · 2026

More from Insights into Imaging

More from Chongqing University

More from Siemens Healthcare (Germany)

More from North Sichuan Medical University

More from Chongqing Cancer Hospital

More from Siemens (China)